Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Melrose Industries (MRO) by Zaven Boyrazian in The Motley Fool
- Avoid THG (THG) by Steve Moore in ShareProphets
- Avoid Thruvision Group (THRU) by Steve Moore in ShareProphets
- Sell Fusion Antibodies (FAB) by Steve Moore in ShareProphets
- Avoid DP Poland (DPP) by Steve Moore in ShareProphets
- Avoid Corero Network Security (CNS) by Steve Moore in ShareProphets
- Watch Robert Walters (RWA) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Oxford Instruments (OXIG) by Steve Moore in ShareProphets
- Watch Pagegroup (PAGE) by Steve Moore in ShareProphets
- Avoid Everyman Media Group (EMAN) by Steve Moore in ShareProphets
- Hold Burberry Group (BRBY) by William Kay in The Times - Tempus
- Avoid Cavendish Financial (CAV) by Tom Winnifrith in ShareProphets
- Avoid Thruvision Group (THRU) by Steve Moore in ShareProphets
- Avoid Hays (HAS) by Steve Moore in ShareProphets
- Avoid ActiveOps (AOM) by Steve Moore in ShareProphets
- Strong Buy KEFI Gold and Copper (KEFI) by Tom Winnifrith in ShareProphets
- Buy Marks & Spencer Group (MKS) by Robert Stephens (The Times) in The Times - Tempus
- Add Land Securities Group (LAND) by Harvey Jones in The Motley Fool
- Hold Mincon Group (CDI) (MCON) by Hot Stock Rockets in ShareProphets
Oxford Biomedica (OXB) Share Price
Health Care Sector
NOTE: This is based on 155 open tips for Oxford Biomedica (OXB)
| Latest Bid : 508.00p | Latest Ask : 512.00p |
| High Today : 525.00p | Low Today : 510.00p |
| This Years High : 913.00p | This Years Low : 424.00p |
| Volume : 70,076 | MKT Cap : £534.45M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000
Oxford Biomedica (OXB) Overview
Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.Oxford Biomedica (OXB) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2026-08-18 18:00:00 18/08/2026 | 1.60% |
| Outperform | RBC Capital | Premium Only | 2026-08-10 09:41:00 10/08/2026 | 4.62% |
| Buy | William Kay | Premium Only | 2026-07-29 09:40:00 29/07/2026 | -8.78% |
| Outperform | RBC Capital | Premium Only | 2026-06-24 09:37:00 24/06/2026 | -16.14% |
| Buy | Simon Watkins | Premium Only | 2026-06-22 07:00:00 22/06/2026 | -16.14% |
Oxford Biomedica (OXB) Recent Short Position Updates
| Position | Date |
|---|---|
| 8.31% | 25/09/2026 |
| 6.14% | 09/09/2026 |
| Latest Bid : 508.00p | Latest Ask : 512.00p |
| High Today : 525.00p | Low Today : 510.00p |
| This Years High : 913.00p | This Years Low : 424.00p |
| Volume : 70,076 | MKT Cap : £534.45M |
Oxford Biomedica Overview
Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Oxford Biomedica Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Deutsche Bank | Premium Only | 2026-08-18 18:00:00 18/08/2026 | 1.60% |
| Outperform | RBC Capital | Premium Only | 2026-08-10 09:41:00 10/08/2026 | 4.62% |
| Buy | William Kay | Premium Only | 2026-07-29 09:40:00 29/07/2026 | -8.78% |
| Outperform | RBC Capital | Premium Only | 2026-06-24 09:37:00 24/06/2026 | -16.14% |
| Buy | Simon Watkins | Premium Only | 2026-06-22 07:00:00 22/06/2026 | -16.14% |
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000